Down's syndrome screening

M Gill

Comment

M Gill. Lancet. 1996.

. 1996 Jun 8;347(9015):1625.

M Gill

No abstract available

Comment on

Down's syndrome screening in the UK.
Nicolaides KH, Sebire NJ, Snijders RJ, Johnson S. Nicolaides KH, et al. Lancet. 1996 Mar 30;347(9005):906-7. doi: 10.1016/s0140-6736(96)91391-4. Lancet. 1996. PMID: 8622427 No abstract available.

Down's syndrome screening.
Haddow JE, Palomaki GE. Haddow JE, et al. Lancet. 1996 Jun 8;347(9015):1625; author reply 1625-6. Lancet. 1996. PMID: 8667893 No abstract available.
Down's syndrome screening in the UK.
Nicolaides KH, Sebire NJ, Snijders RJ, Johnson S. Nicolaides KH, et al. Lancet. 1996 Mar 30;347(9005):906-7. doi: 10.1016/s0140-6736(96)91391-4. Lancet. 1996. PMID: 8622427 No abstract available.
Prenatal biochemical screening for Down's syndrome and neural tube defects.
Wald NJ, Kennard A. Wald NJ, et al. Curr Opin Obstet Gynecol. 1992 Apr;4(2):302-7. Curr Opin Obstet Gynecol. 1992. PMID: 1373963 Review.
Impact of a regional screening programme using maternal serum alpha fetoprotein (AFP) and human chorionic gonadotrophin (hCG) on the birth incidence of Down's syndrome in the west of Scotland.
Crossley JA, Aitken DA, Berry E, Connor JM. Crossley JA, et al. J Med Screen. 1994 Jul;1(3):180-3. doi: 10.1177/096914139400100309. J Med Screen. 1994. PMID: 8790513
[An analysis of the causes for the occurrence of Down's syndrome and the current approaches to its prevention at the stage of mass prenatal ultrasonic and immunobiochemical screening of pregnant women].
Veropotvelian NP, Veropotvelian PN, Korotkov AV. Veropotvelian NP, et al. Tsitol Genet. 1995 Sep-Oct;29(5):82-92. Tsitol Genet. 1995. PMID: 8721852 Review. Russian.